Found 9693 bookmarks
Newest
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy - PubMed
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy - PubMed
In the past decades, food allergies became increasingly dominant since early childhood, leading to a lower quality of life and to increasing costs addressed by the health care system. Beside standard avoidance of specific allergens and drug treatments following allergen exposure, a great deal of res …
·pubmed.ncbi.nlm.nih.gov·
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy - PubMed
Detection of gastrointestinal pathogens in stool samples using a rapid multiplex PCR test at a large tertiary pediatric hospital - PubMed
Detection of gastrointestinal pathogens in stool samples using a rapid multiplex PCR test at a large tertiary pediatric hospital - PubMed
Acute gastrointestinal infections (AGIs) and diarrheal disease disproportionately impact children. The purpose of this study was to characterize the clinical and epidemiological characteristics of pediatric patients who had stool samples tested using the BIOFIRE® FILMARRAY® Gastrointestinal Panel at …
·pubmed.ncbi.nlm.nih.gov·
Detection of gastrointestinal pathogens in stool samples using a rapid multiplex PCR test at a large tertiary pediatric hospital - PubMed
Antibiotic subclasses differentially perturb the gut microbiota in kidney transplant recipients - PubMed
Antibiotic subclasses differentially perturb the gut microbiota in kidney transplant recipients - PubMed
Beta-lactam antibiotics and FQ antibiotics have a profound impact on the gut microbiota in kidney transplant recipients. Given the link of the gut microbiota to infectious complications, antibiotic associated changes in the microbiota may lead to an increased risk for further infections.
·pubmed.ncbi.nlm.nih.gov·
Antibiotic subclasses differentially perturb the gut microbiota in kidney transplant recipients - PubMed
Gut Bacteria in Alcohol-Associated Liver Disease - PubMed
Gut Bacteria in Alcohol-Associated Liver Disease - PubMed
Alcohol-associated liver disease (ALD) poses a significant global public health challenge, with high patient mortality rates and economic burden. The gut microbiome plays an important role in the onset and progression of alcohol-associated liver disease. Excessive alcohol consumption disrupts the in …
·pubmed.ncbi.nlm.nih.gov·
Gut Bacteria in Alcohol-Associated Liver Disease - PubMed
Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs - PubMed
Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs - PubMed
The increasing prevalence of autoimmune and immune-mediated diseases (AIMDs) underscores the need to understand environmental factors that contribute to their pathogenesis, with the microbiome emerging as a key player. Despite significant advancements in understanding how the microbiome influences p …
·pubmed.ncbi.nlm.nih.gov·
Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs - PubMed
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission - PubMed
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission - PubMed
Bacteriophages are influential within the human gut microbiota, yet they remain understudied relative to bacteria. This is a limitation of studies on fecal microbiota transplantation (FMT) where bacteriophages likely influence outcome. Here, using metagenomics, we profile phage populations - the pha …
·pubmed.ncbi.nlm.nih.gov·
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission - PubMed
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products - PubMed
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products - PubMed
The human intestine hosts a complex ecosystem of various microorganisms, collectively known as the gut microbiome, which significantly impacts human health. Disruptions in the gut microbiome are linked to various disorders, including gastrointestinal diseases, such as Clostridioides difficile …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products - PubMed
Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions - PubMed
Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions - PubMed
Ischemic stroke (IS) is the predominant form of stroke pathology, and its clinical management remains constrained by therapeutic time frame. The gut microbiota (GM), comprising a multitude of bacterial and archaeal cells, surpasses the human cell count by approximately tenfold and significantly cont …
·pubmed.ncbi.nlm.nih.gov·
Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions - PubMed
Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis - PubMed
Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis - PubMed
The prevalence of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) and carbapenem-resistant Enterobacterales (CRE) has become a global public health problem. ESBL-E/CRE colonization can increase the risk of infection in patients and lead to poor disease prognosis. We conducted a sys …
·pubmed.ncbi.nlm.nih.gov·
Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis - PubMed
Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome - PubMed
Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome - PubMed
Patients in the acute phase of neuromyelitis optica spectrum disorder (NMOSD) exhibited imbalances in their gut microbiota and a deficiency in short-chain fatty acids (SCFAs). Following drug treatment, the composition of intestinal microbes in NMOSD patients during the remission phase closely resemb …
·pubmed.ncbi.nlm.nih.gov·
Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome - PubMed
Unveiling the impact of antibiotic stress on biofilm formation and expression of toxin-antitoxin system genes in Clostridium difficile clinical isolates - PubMed
Unveiling the impact of antibiotic stress on biofilm formation and expression of toxin-antitoxin system genes in Clostridium difficile clinical isolates - PubMed
Our study suggests that toxin and antitoxin genes may impact C. difficile biofilm formation, while antibiotics could signal biofilm strengthening and gene expression increase.
·pubmed.ncbi.nlm.nih.gov·
Unveiling the impact of antibiotic stress on biofilm formation and expression of toxin-antitoxin system genes in Clostridium difficile clinical isolates - PubMed
[Clostridioides difficile infections: Update and therapeutic guidelines] - PubMed
[Clostridioides difficile infections: Update and therapeutic guidelines] - PubMed
Clostridioides difficile infection (CDI) represents a significant challenge due to its increasing incidence, severity, and treatment difficulty. Effective management requires a multifactorial approach that includes preventive strategies, prudent antibiotic use, and adapted therapeutic options. Ongoi …
·pubmed.ncbi.nlm.nih.gov·
[Clostridioides difficile infections: Update and therapeutic guidelines] - PubMed
Exploring the role of gut microbiome in autoimmune diseases: A comprehensive review - PubMed
Exploring the role of gut microbiome in autoimmune diseases: A comprehensive review - PubMed
As the industrialized society advances, there has been a gradual increase in the prevalence of autoimmune disorders. A probe into the fundamental causes has disclosed several factors in modern society that have an influence on the gut microbiome. These dramatic shifts in the gut microbiome are likel …
·pubmed.ncbi.nlm.nih.gov·
Exploring the role of gut microbiome in autoimmune diseases: A comprehensive review - PubMed
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey - PubMed
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey - PubMed
Conditions of transplant manufacturing, bowel cleansing, and a route of delivery tailored to the patient's characteristics are key factors in optimising FMT efficacy. FMT at first recurrence showed high success in real-life practice, whereas it had lower efficacy in severe CDI and non-severe refract …
·pubmed.ncbi.nlm.nih.gov·
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey - PubMed
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review - PubMed
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review - PubMed
The human gastrointestinal (GI) tract microbiome is a complex and all-encompassing ecological system of trillions of microorganisms. It plays a vital role in digestion, disease prevention, and overall health. When this delicate balance is disrupted, it can lead to various health issues. Fecal microb …
·pubmed.ncbi.nlm.nih.gov·
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review - PubMed
The role of the gut microbiota in neurodegenerative diseases targeting metabolism - PubMed
The role of the gut microbiota in neurodegenerative diseases targeting metabolism - PubMed
In recent years, the incidence of neurodegenerative diseases (NDs) has gradually increased over the past decades due to the rapid aging of the global population. Traditional research has had difficulty explaining the relationship between its etiology and unhealthy lifestyle and diets. Emerging evide …
·pubmed.ncbi.nlm.nih.gov·
The role of the gut microbiota in neurodegenerative diseases targeting metabolism - PubMed
Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center - PubMed
Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center - PubMed
In the present study, despite its small size, FMT through colonoscopy was shown to be a safe, effective, and lasting therapy in cases of recurrent CDI, concurring with results from larger studies.
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation through colonoscopy in the treatment of recurrent Clostridioides difficile: Experience at a university center - PubMed
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection - PubMed
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection - PubMed
Recurrent C. difficile infection (rCDI) is an urgent public health threat, for which the last resort and lifesaving treatment is a fecal microbiota transplant (FMT). However, the exact mechanisms that mediate a successful FMT are not well-understood. Here, we use longitudinal stool samples co …
·pubmed.ncbi.nlm.nih.gov·
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection - PubMed
Microbiota restoration for recurrent Clostridioides difficile infection - PubMed
Microbiota restoration for recurrent Clostridioides difficile infection - PubMed
Since the publication of the recent North American and European guidelines on management of Clostridioides difficile infection (CDI), new evidence describing the epidemiology, testing and treatment of CDI has emerged. Despite all advances in infection control and antibiotic stewardship, the incidenc …
·pubmed.ncbi.nlm.nih.gov·
Microbiota restoration for recurrent Clostridioides difficile infection - PubMed
Ulcerative colitis: molecular insights and intervention therapy - PubMed
Ulcerative colitis: molecular insights and intervention therapy - PubMed
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by abdominal pain, diarrhea, rectal bleeding, and weight loss. The pathogenesis and treatment of UC remain key areas of research interest. Various factors, including genetic predisposition, immune dysregulation, and altera …
·pubmed.ncbi.nlm.nih.gov·
Ulcerative colitis: molecular insights and intervention therapy - PubMed
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments? - PubMed
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments? - PubMed
The bidirectional interaction between the gut and the central nervous system (CNS), the so-called gut microbiota-brain axis, is reported to influence brain functions, thus having a potential impact on the development or the progression of several neurodegenerative disorders. Within this context, it …
·pubmed.ncbi.nlm.nih.gov·
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments? - PubMed
Safety and Tolerability of CP101, a full spectrum, oral microbiome therapeutic for the prevention of recurrent C. difficile infection: A Phase 2 Randomized Controlled Trial - PubMed
Safety and Tolerability of CP101, a full spectrum, oral microbiome therapeutic for the prevention of recurrent C. difficile infection: A Phase 2 Randomized Controlled Trial - PubMed
CP101 was superior to placebo in reducing recurrent CDI with a safety profile similar to placebo. https://clinicaltrials.gov/study/NCT03110133.
·pubmed.ncbi.nlm.nih.gov·
Safety and Tolerability of CP101, a full spectrum, oral microbiome therapeutic for the prevention of recurrent C. difficile infection: A Phase 2 Randomized Controlled Trial - PubMed
Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods - PubMed
Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods - PubMed
Bacterial viability assessment in stool filtrate using the membrane integrity method offers robust and precise data, making it a suitable option for faecal material evaluation in FMT. In contrast, the cultivation-dependent methods produce inconsistent outcomes.
·pubmed.ncbi.nlm.nih.gov·
Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods - PubMed
New mRNA vaccine created to prevent and treat C. difficile
New mRNA vaccine created to prevent and treat C. difficile
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal models, this first mRNA-LNP C. difficile vaccine was found to protect against C. difficile first-time infections and relapsing infections by inducing a robust immune response, promote clearance of existing C. diff bacteria from the gut, and even overcome deficits in host immunity to protect animals after infection, according to researchers. The results will pave the way for clinical trials of the vaccine.
·sciencedaily.com·
New mRNA vaccine created to prevent and treat C. difficile